Business Insider: US FDA approved IND submitted by Pharmazz, Inc. to initiate a phase III clinical trial of centhaquine in patients with hypovolemic shock
US FDA approved IND submitted by Pharmazz, Inc. to initiate a phase III clinical trial of centhaquine in patients with hypovolemic shock
Pharm Exec: Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock
Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock
Hypovolemic shock happens when a drop in blood volume — usually due to bleeding — leads to severe complications, including organ failure. Symptoms include a rapid heart rate and breathing difficulty.
Business Wire: Vivacelle Bio’s VBI-S Phase IIa Clinical Trial Meets Primary and Secondary Endpoints for Treating Hypovolemia in Septic Shock Patients
Vivacelle Bio’s VBI-S Phase IIa Clinical Trial Meets Primary and Secondary Endpoints for Treating Hypovolemia in Septic Shock Patients
Hypovolemic shock is a dangerous condition that happens when you suddenly lose a lot of blood or fluids from your body. This drops your blood volume, the amount of blood circulating in your body. That ...